Where does Exthera Medical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Exthera Medical Corporation ranks #14,608 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Exthera Medical Corporation hold?

Exthera Medical Corporation holds 20 US utility patents granted between 2015 and 2024, spanning 11 technology areas.

What is Exthera Medical Corporation's Innovation Score?

Exthera Medical Corporation has an Innovation Score of 34.5 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Exthera Medical Corporation's patent grant rate increasing or decreasing?

Exthera Medical Corporation's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Exthera Medical Corporation's patents?

Exthera Medical Corporation's patents average 14.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Exthera Medical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Exthera Medical Corporation

Q: What technology areas does Exthera Medical Corporation focus on?

Exthera Medical Corporation's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 17 patents, ranking #438 of 3,490 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 20 granted patents across 11 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Exthera ranks #14,608 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 11 technology areas.

#14,608
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.5/100): 14.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14608 · US Corporation #14,608 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,608/49,997
PHOTO-FINISH Earthway Products
CPC-FOCUS A61M · 11 areas
INNOV-THIN 34.5/100
CLAIMS-RICH 14.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Earthway Products, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Exthera’s 34.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (31%) Velocity 3.3 pts (10%) Breadth 11.7 pts (34%) Claim depth 8.9 pts (26%)

Qualcomm Incorporated · highest

85
Exthera Medical · this assignee

34
3D Lighting… · lowest

7

What this shows Exthera's Innovation Score is 34.5/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Exthera?

Each dot is one of Exthera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Exthera’s own 14.8 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Exthera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Exthera's grants concentrate

Exthera Medical Corporation is a focused PatentsView assignee: 11 CPC subclasses with 85% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2015. By volume, Exthera sits between Escape Fitness Limited and Elanco Tiergesundheit AG.

Exthera's three-year grant acceleration

Exthera Medical Corporation shows 5 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Escape Fitness

20
Etymotic Research

20
European Aeronaut…

20
EV Group

20
Earthway Products

20
East Tennessee St…

20
Ecofactor

20
Elanco Tiergesund…

20
Exthera Medical ◀

20

What this shows Exthera holds 20 patents at rank #14,590, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Exthera

By rank, the assignees closest to #14,590 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Exthera's primary technology class.

Exthera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Exthera Medical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.0%
2016	1	5.0%
2017	2	10.0%
2018	1	5.0%
2019	3	15.0%
2020	5	25.0%
2021	2	10.0%
2022	2	10.0%
2023	1	5.0%
2024	2	10.0%

Which technologies does Exthera Medical Corporation patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

Y02A - Technologies FOR Adaptation TO Climate Change 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

B01D - Separation 7

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

A61B - DIAGNOSIS; SURGERY; Identification 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Exthera Medical Corporation's patent record in context - here's where to go next.

Exthera Medical Corporation's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 85% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #14,608 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Exthera Medical Corporation against Escape Fitness Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.